- Home
- KZIA vs JRVR Comparison
KZIA vs JRVR Comparison
Compare KZIA & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KZIA | JRVR |
|---|---|---|
| Founded | 1994 | 2002 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.7M | 209.9M |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KZIA | JRVR |
|---|---|---|
| Price | $8.09 | $3.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $28.33 | $4.72 |
| AVG Volume (30 Days) | 229.9K | ★ 258.2K |
| Earning Date | 11-06-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | ★ 125.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $687,614,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.86 | $3.36 |
| 52 Week High | $17.40 | $7.20 |
Technical Indicators
Market Signals| Indicator | KZIA | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 66.68 |
| Support Level | $6.72 | $3.96 |
| Resistance Level | $8.18 | $4.26 |
| Average True Range (ATR) | 0.67 | 0.12 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 48.51 | 96.83 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.